← Open Payments lookup

SAAD SHAMMAS: Open Payments

NPI 1124319298 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 23 payments from 9 companies in 2025. Trend: 2023 $496 · 2024 $347 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
Novo Nordisk Inc5$279
Amgen Inc.5$174
AstraZeneca Pharmaceuticals LP6$145
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35
Exact Sciences Corporation1$31
Lilly USA, LLC1$27
PFIZER INC.1$21
Abbott Laboratories1$19
Paratek Pharmaceuticals, Inc.1$18

Products named: Ozempic, REPATHA, OTEZLA, BREZTRI, AIRSUPRA, XIFAXAN, Rybelsus, Cologuard Collection Kit.

Industry payments across TX — which companies pay providers there.